Revive Therapeutics To Raise Up To $5M Via Private Placement
Revive Therapeutics To Raise Up To $5M Via Private Placement
REVIVE THERAPEUTICS LTD. (OTCQB:RVVTF) (CSE:RVV) announced that it is arranging a private placement of a minimum of $3 million and up to $5 million of units, at a price of $0.15 per unit;. The offering is being led by EMD Financial Inc.
復興治療有限公司。(OTCQB：RVVTF)(CSE：RVV)宣佈安排私募最低300萬美元和最高可達500萬美元的單位, 售價0.15美元每單位；此次發行由以下公司牽頭EMD金融公司.
Each unit shall be comprised of one common share in the capital of the company and one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to acquire one additional common share at a price of $0.20 for a period of thirty-six months from the closing date of the offering.
每單位由一股公司股本普通股和一份公司普通股認購權證組成。每份認股權證持有人有權以0.20美元的價格額外購買一股普通股，期限為自發售結束之日起36個月。
The company intends to use the net proceeds for general working capital purposes and clinical development.
該公司打算將淨收益用於一般營運資金用途和臨牀開發。
In connection with the offering, the company will pay finder's fees and issue finder warrants to EMD Financial Inc. as well as any other registrants participating in the offering consisting of: cash finder's fees of up to 8% of the gross proceeds of the offering and finder warrants in an amount equal to up to 8% of the number of units issued pursuant to the offering, exercisable at a price of $0.15 per common share for a period of thirty-six months following the closing date.
與此次發售相關的是，該公司將向EMD金融公司以及參與此次發售的任何其他註冊人支付尋金手續費，並向參與發售的任何其他註冊人發行尋得股權證，包括：最高為發售總收益的8%的現金尋回手續費和金額不超過根據發售發行的單位數量的8%的尋回股權證，可在交易截止日期後的36個月內以每股普通股0.15美元的價格行使。
The units offered as a part of the offering shall be offered to purchasers resident in all provinces of Canada, except Québec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106. The company may issue up to an aggregate of 33.33 million units for maximum aggregate gross proceeds of $5 million under the listed issuer financing exemption. Units offered under the listed issuer financing exemption will not be subject to resale restrictions pursuant to applicable Canadian securities laws.
根據NI 45-1065A部分下的上市發行人融資豁免，作為發售一部分的發售單位應向居住在加拿大所有省份(QuéBEC除外)的買家發售。該公司可以發行最多一份總計3333萬套上市發行人融資豁免項下的最高總收益總額為500萬美元。根據適用的加拿大證券法，根據上市發行人融資豁免提供的單位將不受轉售限制。
The offering is anticipated to close on or about December 14, 2022, or such later date as the company may determine. The closing is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals, including the approval of the Canadians Securities Exchange.
這份禮物是預計於2022年12月14日左右關閉，或公司決定的較後日期。成交取決於某些條件，包括但不限於獲得所有必要的監管和其他批准，包括加拿大證券交易所的批准。
Get your daily dose of cannabis news on Benzinga Cannabis. Don't miss out on any important developments in the industry.
獲取您的每日大麻用量新聞 在本辛加大麻上。不要錯過對該行業任何重要發展的期望。
Photo by Mackenzie Marco on Unsplash
Mackenzie Marco在Unspash上的照片
Related News
相關新聞
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
大型迷幻藥公司正在研究魔力蘑菇治療冰毒成癮